Announcements

Taysha Gene Therapies, Inc. filed its Form 10-Q for the quarterly period ended June 30, 2026 with the U.S. Securities and Exchange Commission on August 11, 2026, disclosing a net loss of $46.6 million for the second quarter and cash of $455.4 million following …

Absci Corporation (NASDAQ:ABSI), a drug creation company based in Vancouver, Washington, filed its Form 10-Q for the quarterly period ended June 30, 2026, with the U.S. Securities and Exchange Commission on August 11, 2026.

Taysha Gene Therapies, Inc. filed a Form 8-K with the SEC on August 11, 2026, reporting financial results for the quarter ended June 30, 2026, along with recent business highlights furnished as a press release.

Achieve Life Sciences, Inc. filed its quarterly report on Form 10-Q with the U.S. Securities and Exchange Commission for the quarterly period ended June 30, 2026, with the filing dated August 11, 2026.

Carrie J. Powers, Vice President and Controller of Union Pacific Corp, filed a statement of changes in beneficial ownership on August 11, 2026, reporting a share acquisition in the company's common stock dated August 10, 2026.

A Form 4 filed on August 11, 2026 disclosed that Amy M. Rothstein, a director of Arlo Technologies, Inc. (NASDAQ:ARLO), sold 9,251 shares of common stock on August 7, 2026 under a pre-established Rule 10b5-1 trading plan.

Amy Christine Friedrich, President - Benefits & Protection at Principal Financial Group Inc (NASDAQ:PFG), filed a Form 4 on August 11, 2026, disclosing stock option exercises and a same-day share sale transacted on August 7, 2026.